3Z Pharmaceuticals (private company)

See something wrong or missing? Let us know
Offices:
Reykjavik
Business model:
B2B
Investors:
we tracked 4 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

3Z was founded in 2008 by Karl Karlsson, Reykjavik University, and Haraldur Thorsteinsson. It originates from RU neurolab, a Reykjavik University based neuroscience laboratory, in which a zebrafish model of sleep has been in development since 2006.

Karl Karlsson is a professor at the School of Science and Engineering at Reykjavik University. He obtained a Phd in Behavioral Neuroscience from Iowa University in 2005. In 2006 Karlsson started RU Neurolab, a laboratory focused on the neurobiology of sleep and wake. Haraldur Thorsteinsson joined RU Neurolab in 2008. He received an MSc. in Neuropsychology from the University of Maastricht in 2008.

At RU Neurolab a zebrafish model for studying sleep and wake physiology has been developed and is currently employed in high throughput screening. Other core methods employed in the lab include automated behavioral analysis, basic genetics, histology and in vivo/in vitro electrophysiology.

Companies with similar profile to 3Z Pharmaceuticals:

CompanyCriteria
Sweden Asarina Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Ilya Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Denmark Cope IT
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Trialbee
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Norway Avexxin
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Sweden Athera
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Iceland Mint Solutions
34%
  • Similar verticals: Health services
  • At least one vc investor: NSA Ventures
  • Minim one investor from outside Scandinavia: Yes
Sweden Vironova
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Norway Vaccibody
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Denmark MagCath
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Finland Blueprint Genetics
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Mevia
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Sweden Modus Therapeutics
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Finland BC Platforms
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Inhalation Sciences
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Finland Optomed
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Finland Synoste Oy
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Finland Klinik
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Denmark Absolute Liquid Solutions
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Norway No Isolation
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD